MG
CVS icon

Mather Group’s CVS Health CVS Stock Holding History

Mather Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$697K Buy
9,701
+4,113
+74% +$317K 0.01% 416
2025
Q4 		$443K Buy
5,588
+840
+18% +$66.2K ﹤0.01% 435
2025
Q3 		$358K Buy
+4,748
New +$325K ﹤0.01% 467
2025
Q2 		– Sell
-2,893
Closed -$196K – 864
2025
Q1 		$196K Buy
2,893
+108
+4% +$6.46K ﹤0.01% 597
2024
Q4 		$125K Sell
2,785
-682
-20% -$38.3K ﹤0.01% 692
2024
Q3 		$218K Sell
3,467
-8,121
-70% -$474K ﹤0.01% 546
2024
Q2 		$924K Buy
11,588
+3,512
+43% +$220K 0.01% 277
2024
Q1 		$638K Sell
8,076
-9
-0.1% -$687 0.01% 289
2023
Q4 		$638K Buy
8,085
+2,181
+37% +$155K 0.01% 296
2023
Q3 		$412K Buy
5,904
+120
+2% +$8.5K 0.01% 367
2023
Q2 		$400K Sell
5,784
-4,459
-44% -$317K 0.01% 396
2023
Q1 		$761K Sell
10,243
-664
-6% -$55.7K 0.01% 254
2022
Q4 		$1.02M Sell
10,907
-414
-4% -$39.9K 0.02% 210
2022
Q3 		$1.08M Buy
11,321
+546
+5% +$54K 0.02% 185
2022
Q2 		$998K Buy
10,775
+80
+0.7% +$7.81K 0.02% 184
2022
Q1 		$1.08M Buy
10,695
+8
+0.1% +$840 0.02% 162
2021
Q4 		$1.1M Buy
10,687
+7,726
+261% +$714K 0.02% 143
2021
Q3 		$251K Sell
2,961
-45
-1% -$3.77K 0.01% 243
2021
Q2 		$251K Buy
3,006
+13
+0.4% +$1.06K 0.01% 238
2021
Q1 		$225K Buy
2,993
+13
+0.4% +$947 0.01% 238
2020
Q4 		$204K Sell
2,980
-480
-14% -$31.2K 0.01% 238
2020
Q3 		$202K Buy
+3,460
New +$215K 0.01% 231
2020
Q1 		– Sell
-2,898
Closed -$215K – 149
2019
Q4 		$215K Buy
+2,898
New +$203K 0.01% 158

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mather Group's CVS Position: Q1 2026 in Review

Mather Group increased its CVS Health (CVS) stake by 74% in Q1 2026, buying an estimated $317K and bringing the position to 9,701 shares worth $697K. The position accounts for 0.01% of the portfolio, ranked #416.

Mather Group first reported a position in CVS in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.1M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Mather Group held 9,701 shares of CVS Health worth $697K as of Q1 2026.
  • Mather Group bought 4,113 CVS Health shares in Q1 2026, an estimated $317K.
  • CVS Health made up 0.01% of Mather Group's portfolio in Q1 2026, its #416 holding.
  • Mather Group first reported a position in CVS Health in Q4 2019 and has held it in 23 quarters since.
  • Mather Group's CVS Health position peaked at $1.1M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.